Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Monday, April 20, 2015

Egypt: New hep C treatment to hit Egyptian market in May

CAIRO: A new drug for treating hepatitis C will be available on the Egyptian market early next month, Health Minister Adel al-Adawy announced Monday.

A 30,000-dose shipment of Olisio, the new treatment, has arrived in Egypt, and is currently undergoing tests before release on the market, the head of National Committee for the Control of Viral Hepatitis Waheed Doss told Youm 7.

Doss added that once Olisio is approved, the treatment protocol will be changed and the new drug will be used simultaneously with the currently-used American-made Sovaldi.

Read more...

No comments:

Post a Comment